| NME | Xpovio | selinexor | To treat adult patients with relapsed or refractory multiple myeloma (RRMM) | Press Release | | 2019/07/03 | KARYOPHARM THERAPEUTICS INC |
| Biologics | Polivy | polatuzumab vedotin-piiq | To treat adult patients with relapsed or refractory diffuse large B-cell lymphoma | Press Release | | 2019/06/10 | GENENTECH |
| NME | Piqray | alpelisib | To treat breast cancer | Press Release | Drug Trials Snapshot | 2019/05/24 | NOVARTIS PHARMS CORP |
| NME | Vyndaqel | tafamidis meglumine | To treat heart disease (cardiomyopathy) caused by transthyretin mediated amyloidosis (ATTR-CM) in adults | Press Release | Drug Trials Snapshot | 2019/05/03 | FOLDRX PHARMS |
| Biologics | Skyrizi | risankizumab-rzaa | To treat moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy | | Drug Trials Snapshot | 2019/04/23 | ABBVIE INC |
| NME | Balversa | erdafitinib | To treat adult patients with locally advanced or metastatic bladder cancer | Press Release | Drug Trials Snapshot | 2019/04/12 | JANSSEN BIOTECH |
| Biologics | Evenity | romosozumab-aqqg | To treat osteoporosis in postmenopausal women at high risk of fracture | Press Release | Drug Trials Snapshot | 2019/04/09 | AMGEN INC |
| NME | Mayzent | siponimod | To treat adults with relapsing forms of multiple sclerosis | Press Release | Drug Trials Snapshot | 2019/03/26 | NOVARTIS PHARMS CORP |
| NME | Sunosi | solriamfetol | To treat excessive sleepiness in adult patients with narcolepsy or obstructive sleep apnea | | Drug Trials Snapshot | 2019/03/20 | JAZZ |
| NME | Zulresso | brexanolone | To treat postpartum depression (PPD) in adult women | Press Release | Drug Trials Snapshot | 2019/03/19 | SAGE THERAP |
| NME | Egaten | triclabendazole | To treat fascioliasis, a parasitic infestation caused by two species of flatworms or trematodes that mainly the affect the liver, sometimes referred to as “liver flukes” | | Drug Trials Snapshot | 2019/02/13 | NOVARTIS PHARMS CORP |
| Biologics | Cablivi | caplacizumab-yhdp | To treat adult patients with acquired thrombotic thrombocytopenic purpura (aTTP) | Press Release | Drug Trials Snapshot | 2019/02/06 | ABLYNX NV |
| Biologics | JEUVEAU | PRABOTULINUMTOXINA-XVFS | For the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients | | Drug Trials Snapshot | 2019/02/01 | EVOLUS INC |
| Biologics | Elzonris | tagraxofusp-erzs | To treat blastic plasmacytoid dendritic cell neoplasm (BPDCN) | Press Release | Drug Trials Snapshot | 2018/12/21 | STEMLINE THERAPEEUTICS INC |
| Biologics | Ultomiris | ravulizumab | To treat paroxysmal nocturnal hemoglobinuria (PNH) | Press Release | Drug Trials Snapshot | 2018/12/21 | ALEXION PHARM |
| Biologics | Asparlas | calaspargase pegol-mknl | To treat acute lymphoblastic leukemia (ALL) in pediatric and young adult patients age 1 month to 21 years | | Drug Trials Snapshot | 2018/12/20 | SERVIER PHARMA LLC |
| NME | Motegrity | prucalopride | To treat chronic idiopathic constipation | | Drug Trials Snapshot | 2018/12/14 | SHIRE DEV LLC |
| NME | Firdapse | amifampridine | To treat Lambert-Eaton myasthenic syndrome (LEMS) in adults | Press Release | | 2018/11/28 | CATALYST PHARMA INC |
| NME | Xospata | gilteritinib | To treat patients who have relapsed or refractory acute myeloid leukemia (AML) | Press Release | | 2018/11/28 | ASTELLAS |
| NME | Vitrakvi | larotrectinib | To treat patients whose cancers have a specific genetic feature (biomarker) | Press Release | | 2018/11/26 | LOXO ONCOLOGY INC |
